187 related articles for article (PubMed ID: 30024595)
1. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN.
Suo HB; Zhang KC; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
4. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
5. MiR-200a acts as an oncogene in colorectal carcinoma by targeting PTEN.
Li Y; Sun J; Cai Y; Jiang Y; Wang X; Huang X; Yin Y; Li H
Exp Mol Pathol; 2016 Dec; 101(3):308-313. PubMed ID: 27983967
[TBL] [Abstract][Full Text] [Related]
6. Decreased MiR-200a/141 suppress cell migration and proliferation by targeting PTEN in Hirschsprung's disease.
Li H; Tang J; Lei H; Cai P; Zhu H; Li B; Xu X; Xia Y; Tang W
Cell Physiol Biochem; 2014; 34(2):543-53. PubMed ID: 25116353
[TBL] [Abstract][Full Text] [Related]
7. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
Zhang BG; Li JF; Yu BQ; Zhu ZG; Liu BY; Yan M
Oncol Rep; 2012 Apr; 27(4):1019-26. PubMed ID: 22267008
[TBL] [Abstract][Full Text] [Related]
8. miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.
Zhu CL; Gao GS
Asian Pac J Cancer Prev; 2014; 15(20):8595-601. PubMed ID: 25374174
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
Wu Q; Guo R; Lin M; Zhou B; Wang Y
Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression.
Li J; Hu K; Gong G; Zhu D; Wang Y; Liu H; Wu X
Sci Rep; 2017 Feb; 7():41330. PubMed ID: 28145479
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
14. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN.
Zhang H; Liu A; Feng X; Tian L; Bo W; Wang H; Hu Y
Prog Biophys Mol Biol; 2019 Nov; 148():65-72. PubMed ID: 28941804
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.
Lou Y; Yang X; Wang F; Cui Z; Huang Y
Int J Mol Med; 2010 Dec; 26(6):819-27. PubMed ID: 21042775
[TBL] [Abstract][Full Text] [Related]
16. miR-552 promotes ovarian cancer progression by regulating PTEN pathway.
Zhao W; Han T; Li B; Ma Q; Yang P; Li H
J Ovarian Res; 2019 Dec; 12(1):121. PubMed ID: 31815639
[TBL] [Abstract][Full Text] [Related]
17. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
19. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
Gong YB; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
[TBL] [Abstract][Full Text] [Related]
20. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]